Winette van der Graaf
@winettevandergraaf.bsky.social
270 followers 210 following 34 posts
Prof of Med Onc #Sarcoma #AYA cancer #RareCancers @Netherlands Cancer Institute; ErasmusMC; President @EORTC Brussels; Chairman Dutch AYA cancer network #MedSky #OncSky #SARCsky #AYACSM
Posts Media Videos Starter Packs
winettevandergraaf.bsky.social
What an amazing group op people in this consortium.
Grateful for everyone’s contribution!
@strong-aya.bsky.social
Annual meeting # Paris
strong-aya.bsky.social
It’s a wrap! Day 2 of the General Assembly brought inspiring discussions with input from our Patient Advisory Board.

Today's highlights:
• Cancer awareness campaigns that stick
• Update on the federated learning infrastructure and integrated data
• Steps for launching our public information portal
Reposted by Winette van der Graaf
strong-aya.bsky.social
📍 We're in Paris for the #STRONGAYA General Assembly meeting, hosted by Institut Gustave Roussy.

Today, we discussed:
• Sustaining project results & reaching stakeholders
• Ethical health data processing for research
• Patient consent models
• Evaluating & refining our Core Outcome Set
Reposted by Winette van der Graaf
strong-aya.bsky.social
📖 New STRONG AYA Resource:
The Blueprint for building national and pan-European STRONG AYA ecosystems to improve AYA cancer care is now available on our website.

👉 Read the full blueprint with information on data ecosystem structures, governance, standards & challenges: strongaya.eu/wp-content/u...
Reposted by Winette van der Graaf
strong-aya.bsky.social
📄 Publication alert: Recommendations and roadmap to implement minimum standards of specialist adolescent and young adult #AYA cancer care units

Led and co-authored by AYAs under the EU-CAYAS-NET project and featuring STRONG-AYA among EU initiatives.
👉 www.sciencedirect.com/science/arti...
Minimum standards of specialist adolescent and young adult (AYA) cancer care units: recommendations and implementation roadmap
In 2022, according to the Global Cancer Observatory, >115 000 adolescents and young adults (AYAs; aged 15-39 years) were diagnosed with cancer across …
www.sciencedirect.com
winettevandergraaf.bsky.social
Grateful for the collaboration with @youthcancereurope.bsky.social showcasing minimal standards of AYA care units. Much can be found in the Dutch AYAZORGNETWERK.nl but we take the recoomendations into account to further improve the care. Published in @ESMO Open.
winettevandergraaf.bsky.social
Very interesting session with speakers from Japan, India, Slovenia, Jordan, South Africa and South Korea.
Language matters, cultural sensitivity even more, particularly in Quality of Life Research. There’s work to do!

Happy to have introduced the topic showing other global activities @eortc.org
qol.eortc.org
💡 Insightful panel discussion as part of @eortc.org #QualityofLife Group autumn meeting closing plenary session.
We look forward to broadening our collaborations in global context🤝

#QLGmeeting #GivingVoice2Patients
@winettevandergraaf.bsky.social @miekevhr.bsky.social

www.eortc.org/event/eortc-...
Reposted by Winette van der Graaf
eortc.org
🔔 New in @thelancetoncol.bsky.social:
Policy review led by Ian Tannock & Madeline Pe with EORTC & CSO highlights the critical role of patient quality of life data in the evaluation of treatments for people with advanced cancer.
📖Read more: www.eortc.org/blog/2025/09...
#CancerResearch #QualityofLife
Reposted by Winette van der Graaf
eortc.org
📅 Get ready to make the most of EORTC’s upcoming events!

Mark your calendars 👇

#CancerResearch #ClinicalTrials #Oncology #EORTCevents #PatientDays #EBCC15 #Stats2026 #MCCRworkshop #ENASymp26
Reposted by Winette van der Graaf
csoncol.bsky.social
📅 Attending ESMO in Berlin? Don't miss this special CSO Symposium taking place on Fri Oct 17, 5:30-7:00 pm CET.
Moderated by @winettevandergraaf.bsky.social, the panel will discuss recent CSO initiatives & activities in Europe & beyond.

tinyurl.com/5yj9vm8b

@qol.eortc.org #CommonSenseOncology
Common Sense Oncology at ESMO. Join us at the Messe Berlin for a special CSO symposium. Panelists, from left to right: Dr. Winette van der Graaf, Dr. Chris Booth, Dr. Madeline Pe, Dr. Dario Trapani, Dr. Rachel Riechelmann, and Dr. Chris Cronin. Topics, from left to right: CSO and Clinical Trials, CSO Momentum, CSO and QOL, CSO and Education, CSO and Global Oncology, and CSO-EORTC Fellowship. Register now to receive location details.
Reposted by Winette van der Graaf
csoncol.bsky.social
Applications for the 2026 Common Sense Oncology Cancer Health Services Research Fellowship will close on Sept 18, 2025 @ 4 pm EDT. If you are in the clinical or medical oncology field, this opportunity is for you!

View the posting online: tinyurl.com/37cdc5sy

#CommonSenseOncology #CancerCare
Queen's University. Common Sense Oncology Cancer Health Services Research Fellowship. Apply today to help build a cancer care system focused on outcomes that matter.
Reposted by Winette van der Graaf
csoncol.bsky.social
Common Sense Oncology is now on #BlueSky! We are a global network dedicated to advancing innovative patient-centred cancer care & cancer research that meaningfully improves outcomes for patients around the world.

Join us to keep in touch—membership is free!
tinyurl.com/mrjtu9at #CommonSenseOncology
Leaders of Common Sense Oncology standing in front of the pillars of a building.
Reposted by Winette van der Graaf
eortc.org
📢Excited to announce @benjaminbessemd.bsky.social as EORTC President-Elect, starting in June 2026, following @winettevandergraaf.bsky.social 🙌

Also, we welcome the new chairs of the Scientific Chairs Council: Anne-Marie Dingemans and Jean-Pascal Machiels!🔬🎉

👉 www.eortc.org/blog/2025/06...
Reposted by Winette van der Graaf
eclinicalmed.bsky.social
🔍Presenting at #ASCO25 as a #poster and now LIVE on our website

Predictors of withdrawal of anticancer drug indications granted accelerated approval: a retrospective cohort study

Read the whole paper here: www.thelancet.com/journals/ecl...
#TheLancet #Oncology #OncologyResearch #MedSky
Reposted by Winette van der Graaf
eclinicalmed.bsky.social
Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer

Primary prophylactic G-CSF and loperamide led to a clinically relevant reduced incidence and severity of neutropenia and diarrhea

www.thelancet.com/journals/ecl...
#MedSky
winettevandergraaf.bsky.social
For my #sarcoma colleagues and researchers and @HartwigMedicalFoundation @ecuppen.bsky.social
winettevandergraaf.bsky.social
New paper on implementation of WGS in sarcoma routine medical care in a sarcoma expert center. WGS results of 161 STS were assessed. Actionable targets in 46%, subtype specific added value of WGS. Less in fusion pos STS, more in complex ones.

kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...
ScienceDirect.com | Science, health and medical journals, full text articles and books.
kwnsfk27.r.eu-west-1.awstrack.me
winettevandergraaf.bsky.social
Same disappointment. The early days of twitter were so informative! Let’s try harder here!
winettevandergraaf.bsky.social
Immensely proud of my colleague and friend Christopher Booth @Queens’s University Kingston who will present the positive results of Challenge #ASCO25 today. Together with Publication in @nejm.org Impressive work. meetings.asco.org/2025-asco-an...
winettevandergraaf.bsky.social
With dosing and duration that are investigated in clinical trials with relevant outcomes for patients reflecting the whole patient population, for regulators and health systems
winettevandergraaf.bsky.social
A new paper from a workshop on pragmatic clinical trials in cancer organised by @eortc.org published in Lancet Oncology.
Fabulous group of co-authors who took part in the workshop. Access to drugs that matter to
patients as ultimate goal.
eur05.safelinks.protection.outlook.com?url=https%3A...
eur05.safelinks.protection.outlook.com
Reposted by Winette van der Graaf
qol.eortc.org
🤝As the clinical trial landscape evolves, so must our strategies for measuring patients’ #QualityofLife to ensure their voice is incorporated in the decision-making process

🔎Takeaways from new article in @thelancetoncol.bsky.social: www.eortc.org/blog/2025/04...
#GivingVoice2Patients @ema.europa.eu
eortc.org
🔎New in @thelancetoncol.bsky.social: Insights from @ema.europa.eu-EORTC workshop underscore the role of #QualityofLife data in cancer treatment evaluation.

It’s not just about survival-it’s also about how patients live.

Read more in our press release:
www.eortc.org/blog/2025/04...
#CancerResearch
winettevandergraaf.bsky.social
The paper is out!
#Sarcoma genetic predisposition syndromes. Consequences for diagnosis and treatment. Result of an educational session at @ESMO annual meering 2023.

kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...
ScienceDirect.com | Science, health and medical journals, full text articles and books.
kwnsfk27.r.eu-west-1.awstrack.me